0000000000283351

AUTHOR

Lutz Binder

showing 4 related works from this author

Associations of NT-proBNP and parameters of mental health in depressed coronary artery disease patients

2018

Natriuretic peptides (NP) are involved in the regulation of blood pressure and blood volume, and are elevated in patients with coronary artery disease (CAD). They are used as markers for illness severity, but their role in mental health is not well understood. Recently, A-type NP (ANP) has been associated with reduced anxiety in studies on cardiac patients; however, this study is the first to assess this effect for B-type NP (BNP) and for further dimensions of well-being and mental health. Depression, anxiety, and distress are more common in CAD patients than in the general population and are most likely not only influenced by psychological adaptation but also by neurobiological processes. …

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismCoronary Artery DiseaseAnxiety030204 cardiovascular system & hematologyHospital Anxiety and Depression ScaleSeverity of Illness IndexCoronary artery disease03 medical and health sciences0302 clinical medicineEndocrinologyRisk FactorsInternal medicineNatriuretic Peptide BrainSeverity of illnessHumansMedicinecardiovascular diseasesBiological PsychiatryAgedDepressive DisorderDepressionEndocrine and Autonomic Systemsbusiness.industryType D personalityMiddle Agedmedicine.diseaseMental healthPeptide Fragments3. Good healthPsychotherapyPsychiatry and Mental healthDistressMental HealthQuality of LifeAnxietyFemalemedicine.symptombusinessPsychosocialBiomarkers030217 neurology & neurosurgeryPsychoneuroendocrinology
researchProduct

Low N-Terminal pro-B-type Natriuretic Peptide (NT-proBNP) longitudinally predicts elevated anxiety in depressed patients with coronary artery disease

2016

Coronary artery diseasePsychiatry and Mental healthClinical Psychologymedicine.medical_specialtybusiness.industryInternal medicinemedicineCardiologyAnxietyN terminal pro b type natriuretic peptidemedicine.symptommedicine.diseasebusinessJournal of Psychosomatic Research
researchProduct

Brain Natriuretic Peptide and Discovery of Atrial Fibrillation After Stroke

2020

Background and Purpose— Diagnosing paroxysmal atrial fibrillation (pAF) can be challenging after acute ischemic stroke. Enhanced and prolonged Holter-ECG monitoring (EPM) improves the detection rate but is not feasible for all patients. We hypothesized that brain natriuretic peptide (BNP) may help to identify patients with stroke at high risk for pAF to select patients for EPM more effectively. Methods— Patients with acute cerebral ischemia ≥60 years presenting in sinus rhythm and without history of AF were included into a prospective, randomized multicenter study to receive either EPM (3× 10-day Holter-ECG) or usual stroke care diagnostic work-up. BNP plasma levels were measured on random…

Advanced and Specialized Nursingmedicine.medical_specialtyRandomizationbusiness.industryIschemiaAtrial fibrillationPlasma levels030204 cardiovascular system & hematologymedicine.diseaseBrain natriuretic peptide3. Good healthlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineCardiologyMedicineSinus rhythmNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessStroke030217 neurology & neurosurgeryStroke
researchProduct

Longitudinal relationship between B-type natriuretic peptide and anxiety in coronary heart disease patients with depression.

2018

Patients with coronary heart disease (CHD) suffer from physical limitations, but also from psychological distress. Natriuretic peptides may be involved in the neurobiological processes that modulate psychological adaptation, as they are increased in heart disease and seem to have an anxiolytic-like function. Longitudinal data on this association are scarce.To assess the relationship between NT-proBNP and anxiety (Hospital Anxiety and Depression Scale (HADS)), we used secondary data from a multicenter trial from baseline to 24 months. Patients (N = 308, 80.8% male, mean age 60.1 years) had stable CHD and moderate levels of depression (HADS ≥8).Multiple linear regression adjusted for age, sex…

Malemedicine.medical_specialtyHeart diseasemedicine.drug_classDiseaseCoronary Artery DiseaseAnxietyHospital Anxiety and Depression ScaleCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineMulticenter trialNatriuretic Peptide BrainNatriuretic peptideMedicineHumanscardiovascular diseases030212 general & internal medicineLongitudinal StudiesDepression (differential diagnoses)Depressive Disorderbusiness.industryAnxiety ; Coronary Heart Disease ; Depression ; Natriuretic PeptideMiddle Agedmedicine.diseasePeptide FragmentsPsychotherapyPsychiatry and Mental healthClinical PsychologyAnxietyFemalemedicine.symptombusinesshormones hormone substitutes and hormone antagonists030217 neurology & neurosurgeryJournal of psychosomatic research
researchProduct